Condition
Allergic Rhinitis, Seasonal
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Unknown1
Not Yet Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07199257Phase 3Not Yet RecruitingPrimary
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
NCT07154342Phase 3RecruitingPrimary
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
NCT00298337Phase 2Unknown
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
Showing all 3 trials